{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:09:38Z","timestamp":1777554578676,"version":"3.51.4"},"reference-count":38,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Differences in consumer product availability, distribution, and use may lead to national differences in contact sensitization frequencies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of the study was to describe the differences in contact allergy between the United States (US) and Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a retrospective cross-sectional analysis of the North American Contact Dermatitis Group data from 2005 to 2016. Frequencies of demographics, clinical characteristics, positive reactions, trends, and occupations were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 28,640 patients underwent patch testing. At least 1 positive patch test was observed in 18,599 patients (US, 11,641 [66.5%]; Canada, 6958 [62.5%]). When comparing the 2 groups, US positive reactions were more likely to occur in male patients (odds ratio [OR] = 1.40, 95% confidence interval [CI] = 1.31\u20131.49), older than 40 years (OR = 1.30, 95% CI = 1.22\u20131.38), Black (OR = 2.67, 95% CI = 2.24\u20133.19) or Hispanic race (OR = 3.53, 95% CI = 2.61\u20134.78), and\/or patients with scattered generalized dermatitis (OR = 1.96, 95% CI = 1.80\u20132.13). They were less likely to occur in patients with eczema (OR = 0.61, 95% CI = 0.57\u20130.65) and Asian race (OR = 0.50, 95% CI = 0.44\u20130.56). Nickel (US, 16.0%; Canada, 22.4%) and methylisothiazolinone (US, 13.4%; Canada, 11.0%) were the top allergens. The third most frequent was neomycin (US, 11.7%) and fragrance mix I (Canada, 10.2%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>National differences in allergen prevalence and trends exist in North America.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/der.0000000000000701","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T23:00:10Z","timestamp":1625785210000},"page":"421-429","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Contact Allergy in Canada versus United States: Analysis of the North American Contact Dermatitis Group Data 2005\u20132016"],"prefix":"10.1177","volume":"32","author":[{"given":"Amber Reck","family":"Atwater","sequence":"first","affiliation":[{"name":"From the Departments of, *Dermatology, Duke University Medical Center, Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan Maxwell","family":"Ward","sequence":"additional","affiliation":[{"name":"From the Departments of, *Dermatology, Duke University Medical Center, Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beiyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin M.","family":"Warshaw","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Minneapolis Veterans Affairs Medical Center; Department of Dermatology, University of Minnesota, Minneapolis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel G.","family":"DeKoven","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[{"name":"Department of Dermatology, George Washington University School of Medicine and Health Sciences, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Cleveland Clinic Lerner College of Medicine, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald V.","family":"Belsito","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Columbia University Irving Medical Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Joseph F.","family":"Fowler","sequence":"additional","affiliation":[{"name":"Division of Dermatology, University of Louisville, KY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard I.","family":"Maibach","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California Medical School, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margo J.","family":"Reeder","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie D.","family":"Pratt","sequence":"additional","affiliation":[{"name":"Division of Dermatology, University of Ottawa, The Ottawa Hospital, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Zug","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Dartmouth Hitchcock Medical Center, Lebanon, NH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Sasseville","sequence":"additional","affiliation":[{"name":"Division of Dermatology, McGill University Health Centre, Montreal General Hospital, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent A.","family":"DeLeo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"Regulation (EC) N\u00b0 1223\/2009. In: European Union ed 2009."},{"key":"e_1_3_2_3_2","unstructured":"Cosmetic Regulations C.R.C. c. 869. In: Canada ed 2009."},{"key":"e_1_3_2_4_2","unstructured":"FD&C Act Chapter VI: Cosmetics. In: Food and Drug Administration ed. 21. United States. 1938."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2009.01666.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/1203475415623512"},{"issue":"5","key":"e_1_3_2_7_2","first-page":"200","article-title":"National rates and regional differences in sensitization to allergens of the standard series","volume":"37","author":"Schnuch A","year":"1997","unstructured":"Schnuch A, , Geier J, , Uter W, et al. National rates and regional differences in sensitization to allergens of the standard series. Population-adjusted frequencies of sensitization (PAFS) in 40,000 patients from a multicenter study (IVDK). Contact Dermatitis, 1997; 37(5):200\u2013209.","journal-title":"Population-adjusted frequencies of sensitization (PAFS) in 40,000 patients from a multicenter study (IVDK). Contact Dermatitis"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajcd.2002.36643"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2007.06072"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000417"},{"issue":"6","key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0536.2011.01964.x","article-title":"The \u2018overall yield\u2019 with the baseline series\u2014a useful addition to the array of MOAHLFA factors describing departmental characteristics of patch tested patients","volume":"65","author":"Uter W","year":"2011","unstructured":"Uter W, , Schwitulla J, , Thyssen JP, et al. The \u2018overall yield\u2019 with the baseline series\u2014a useful addition to the array of MOAHLFA factors describing departmental characteristics of patch tested patients. Dermatitis, 2011; 65(6):322\u2013328.","journal-title":"Dermatitis"},{"key":"e_1_3_2_12_2","unstructured":"Cheng A. The surprising trend in beauty? Skincare sales growing the fastest among men's grooming products. Forbes 2018. Available at: https:\/\/www.forbes.com\/sites\/andriacheng\/2018\/06\/15\/the-gift-your-dad-really-wants-this-fathers-day-anti-aging-cream\/#76d7078733ba."},{"key":"e_1_3_2_13_2","unstructured":"US Census Bureau. 2010 Census shows America's diversity. Available at: https:\/\/www.census.gov\/newsroom\/releases\/archives\/2010_census\/cb11-cn125.html. Published 2010. Accessed June5 2020."},{"key":"e_1_3_2_14_2","unstructured":"Statistics Canada. Census profile 2016 census. Available at: https:\/\/www12.statcan.gc.ca\/census-recensement\/2016\/dp-pd\/prof\/index.cfm?Lang=E. Published 2017. Accessed June5 2020."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000151"},{"key":"e_1_3_2_16_2","unstructured":"National Library of Medicine. DailyMed. Available at: https:\/\/dailymed.nlm.nih.gov\/dailymed\/. Accessed June11 2020."},{"key":"e_1_3_2_17_2","unstructured":"Government of Canada. Drug product database online query. Available at: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/drug-product-database.html. Published 2019. Accessed June9 2020."},{"issue":"6","key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ad.2013.12.003","article-title":"Allergic contact dermatitis due to nickel: descriptive study in a tertiary hospital, 2000-2010","volume":"105","author":"Garcia-Rabasco AE","year":"2014","unstructured":"Garcia-Rabasco AE, , Zaragoza-Ninet V, , Garcia-Ruiz R, et al. Allergic contact dermatitis due to nickel: descriptive study in a tertiary hospital, 2000-2010. Actas Dermosifiliogr, 2014; 105(6):590\u2013596.","journal-title":"Actas Dermosifiliogr"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13422"},{"key":"e_1_3_2_20_2","volume-title":"Annex XVII","author":"Registration Evaluation","year":"2007","unstructured":"Registration Evaluation, Authorisation and Restriction of Chemicals (REACH). In: Annex XVII. vol. 27. Europe: European Chemicals Agency; 2007."},{"key":"e_1_3_2_21_2","unstructured":"State Administration for Quality Supervision and Inspection and Quarantine. GB 28480. Adornment-Provision for Limit of Baneful Elements. China; 2012."},{"key":"e_1_3_2_22_2","unstructured":"Government of Canada. Nickel facts. Available at: https:\/\/www.nrcan.gc.ca\/our-natural-resources\/minerals-mining\/nickel-facts\/20519. Published 2019. Updated November 27 2019. Accessed August5 2020."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00112-16"},{"issue":"2","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D33PK0X5ZV","article-title":"Trends in the use of topical over the counter products in the management of dermatologic disease in the United States","volume":"18","author":"Nolan BV","year":"2012","unstructured":"Nolan BV, , Levender MM, , Davis SA, et al. Trends in the use of topical over the counter products in the management of dermatologic disease in the United States. Dermatol Online J, 2012; 18(2):1.","journal-title":"Dermatol Online J"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000511"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396-0296.2004.04S1002.x"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2004.20417"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1987.tb02640.x"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1995.tb00522.x"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2015.10.064"},{"key":"e_1_3_2_31_2","unstructured":"Government of Canada. Cosmetic ingredient hotlist. Available at: https:\/\/www.canada.ca\/en\/health-canada\/services\/consumer-product-safety\/cosmetics\/cosmetic-ingredient-hotlist-prohibited-restricted-ingredients\/hotlist.html. Published 2019. Accessed June5 2020."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.061109"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000307"},{"issue":"5","key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"245S","DOI":"10.1177\/1091581812461381","article-title":"Safety assessment of propylene glycol, tripropylene glycol, and PPGs as used in cosmetics","volume":"31","author":"Fiume MM","year":"2012","unstructured":"Fiume MM, , Bergfeld WF, , Belsito DV, et al. Safety assessment of propylene glycol, tripropylene glycol, and PPGs as used in cosmetics. Int J Toxicol, 2012; 31(Suppl 5):245S\u2013260S.","journal-title":"Int J Toxicol"},{"key":"e_1_3_2_35_2","volume-title":"Contact and Occupational Dermatology","author":"Marks JG","year":"2002","unstructured":"Marks JG, , Anderson BE, , DeLeo VA. Contact and Occupational Dermatology. St Louis, MO: Mosby; 2002."},{"key":"e_1_3_2_36_2","first-page":"21","article-title":"Lanolin and derivatives","volume":"101","author":"Barnett G","year":"1986","unstructured":"Barnett G. Lanolin and derivatives. Cosmet Toiletries, 1986; 101:21\u201344.","journal-title":"Cosmet Toiletries"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2009.08081"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0b013e3182937aa4"},{"key":"e_1_3_2_39_2","unstructured":"American Contact Dermatitis Society Contact Allergen Management Program Safe Product List. Available at: http:\/\/www.acdscamp.org\/Search_Allergen. Accessed June16 2020."}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000701","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1097\/DER.0000000000000701","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:06:01Z","timestamp":1777399561000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12,1]]}},"alternative-id":["10.1097\/DER.0000000000000701"],"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000701","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}